Skip to main content

Expert list · Last reviewed April 17, 2026

Top Gastroenterologists for Hepatitis B in New Jersey

Top gastroenterologists for hepatitis B in New Jersey, with liver specialists who manage chronic HBV, cirrhosis risk, and transplant referrals.

Loading map…

New Jersey has a small group of gastroenterologists and hepatologists with deep experience managing chronic hepatitis B, from first diagnosis through cirrhosis and transplant referral. Here is where to start.

If you are searching for the top gastroenterologists for hepatitis B in New Jersey, the right specialist usually has two things: a hepatology focus inside a gastroenterology practice, and ties to a hospital that does liver transplants or has a regional liver disease program. The providers below practice at Rutgers, RWJUH, NYU Langone, Hackensack, Jersey Shore, and Englewood, and they see the full range of hepatitis B, from inactive carriers who need once-a-year monitoring to patients whose livers are failing.

Paul Gaglio

Paul Gaglio, MD

Director, Division of Hepatology and Transplant Hepatology; Medical Director, Liver Transplantation Program; Professor of Medicine, Rutgers New Jersey Medical School

Rutgers New Jersey Medical School

View specialist profile

Dr. Gaglio directs hepatology and the liver transplantation program at Rutgers New Jersey Medical School in Newark, with additional appointments at NewYork-Presbyterian and Hackensack University Medical Center. He treats patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma, and he is one of the few physicians in the state who manages both the medical side of hepatitis B and the transplant evaluation under the same roof. Patients who have been told their hepatitis B is "advanced" or who have been flagged for a liver mass often end up in his clinic.

Nikolaos Pyrsopoulos

Nikolaos Pyrsopoulos, MD,PHD,MBA

Clinical Professor, Department of Medicine at NYU Grossman School of Medicine; Director, Regional Liver Disease, New Jersey

NYU Langone Hospitals

View specialist profile

Dr. Pyrsopoulos directs Regional Liver Disease for New Jersey and is a clinical professor at NYU Grossman School of Medicine, with hospital affiliations at NYU Langone, Overlook, and Morristown Medical Center. His clinical work focuses on chronic viral hepatitis (B and C), fatty liver disease, and decompensated cirrhosis. His research on liver biopsy sampling in chronic hepatitis patients 1 showed that biopsies taken from different parts of the liver can produce different fibrosis scores, which helped push hepatologists toward more careful staging. He has also written on the extrahepatic manifestations of chronic viral hepatitis 3 — the kidney, skin, and joint problems that hepatitis B and C can cause outside the liver.

Dr. Bains is a gastroenterologist affiliated with Clara Maass Medical Center, Jersey City Medical Center, and Saint Michael's Medical Center, with his office in Millburn. He handles the long tail of chronic hepatitis B care: yearly labs, imaging for liver cancer screening, and referrals upstream when a patient's hepatitis progresses. For people who want a community-based specialist close to Essex or Union County rather than a university hospital, he is a straightforward option.

Penny Turtel

Penny Turtel, MD

Chief of Gastroenterology, Jersey Shore University Medical Center

Jersey Shore University Medical Center

View specialist profile

Dr. Turtel is Chief of Gastroenterology at Jersey Shore University Medical Center and also practices at Monmouth Medical Center. Her practice covers the common GI conditions plus viral hepatitis monitoring, and she is the senior gastroenterologist most Jersey Shore primary care offices refer to when a patient tests positive for hepatitis B surface antigen. If you live along the shore and want a hepatitis B specialist without commuting to Newark or New Brunswick, she is a reasonable first call.

Michael Meininger

Michael Meininger, M.D.

Associate Medical Director, Institute for Patient Blood Management and Bloodless Medicine and Surgery at Englewood Hospital; Clinical Instructor of Medicine, Icahn School of Medicine at Mount Sinai

Englewood Hospital and Medical Center

View specialist profile

Dr. Meininger is Associate Medical Director of the Institute for Patient Blood Management and Bloodless Medicine and Surgery at Englewood Hospital, and a clinical instructor at the Icahn School of Medicine at Mount Sinai. He treats patients with chronic liver disease, including hepatitis B, and has a particular focus on managing procedures — biopsies, endoscopies, surgeries — for patients with coagulation problems or who decline blood transfusions for religious reasons. That subspecialty matters for hepatitis B patients whose livers have started making fewer clotting factors.

Vinod Rustgi

Vinod Rustgi, MD

Distinguished Professor of Medicine (Gastroenterology); Director of Hepatology; Professor of Epidemiology; Professor of Pathology & Lab Medicine, Rutgers Robert Wood Johnson Medical School

Robert Wood Johnson University Hospital

View specialist profile

Dr. Rustgi is Distinguished Professor of Medicine and Director of Hepatology at Rutgers Robert Wood Johnson Medical School, practicing at Robert Wood Johnson University Hospital in New Brunswick. His clinic handles hepatitis B, hepatitis C, autoimmune hepatitis, and cirrhosis. He is the senior hepatologist in central New Jersey and a common second-opinion destination for patients who have been on antiviral therapy for years and want to reassess whether to continue, switch, or stop.

What to look for in a gastroenterologist for hepatitis B

  • Board certification in gastroenterology or transplant hepatology
  • Affiliation with a teaching hospital or liver transplant center
  • A practice pattern that includes chronic hepatitis B patients (not just colonoscopies)
  • Access to hepatitis B DNA testing, FibroScan, and liver imaging
  • Wait time and whether they are accepting new patients
  • Compatibility with your insurance, including in-network hospital privileges

Questions to ask before your first appointment

  • How many patients with chronic hepatitis B do you treat each year?
  • Do you offer FibroScan or other non-invasive fibrosis testing?
  • At what point would you start me on antiviral therapy, and at what point would you consider stopping it?
  • How often should I be screened for liver cancer based on my results?
  • If my hepatitis B progresses, do you refer to a transplant program or manage that yourself?
  • What should I do if I become pregnant or if a family member needs testing?

The bottom line

Chronic hepatitis B is a long-term relationship with a specialist, not a one-visit problem. Start with a gastroenterologist who has a hepatology focus and admitting privileges at a hospital that can handle advanced liver disease if you need it. If your current doctor is a general gastroenterologist and your viral load, ALT, or imaging looks concerning, ask for a referral to one of the hepatology programs at Rutgers, RWJUH, Jersey Shore, or Englewood.

Sources

1 Pyrsopoulos N. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. The American Journal of Gastroenterology (2002). Cited 2,063 times.

2 Pyrsopoulos N. Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update. Journal of Clinical and Translational Hepatology (2016). Cited 730 times.

3 Pyrsopoulos N. Extrahepatic manifestations of chronic viral hepatitis. Current Gastroenterology Reports (2001). Cited 163 times.

4 Pyrsopoulos N. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology (2002). Cited 155 times.

5 Pyrsopoulos N. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension. Journal of Hepatology (2019). Cited 155 times.

Sources

  1. 1.
    Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infectionThe American Journal of Gastroenterology, 2002. DOI
  2. 2.
    Acetaminophen-Induced Hepatotoxicity: a Comprehensive UpdateJournal of Clinical and Translational Hepatology, 2016. DOI
  3. 3.
    Extrahepatic manifestations of chronic viral hepatitisCurrent Gastroenterology Reports, 2001. DOI
  4. 4.
    Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsyGastroenterology, 2002. DOI
  5. 5.
    Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertensionJournal of Hepatology, 2019. DOI

Related specialist lists